Chromogranin A and the tumor microenvironment

Cellular and Molecular Neurobiology

Volumn 30, Issue 8, 2010, Pages 1163-1170

  Corti, Angelo ^a  

^a NONE

Author keywords

Angiogenesis; Cell adhesion; Chromogranin A; Endothelial cells; Fibroblasts; Neuroendocrine tumor; Tumor necrosis factor; Tumor stroma; Vascular leakage; VEGF

Indexed keywords

CHROMOGRANIN A;

BREAST CANCER; CANCER PATIENT; CARCINOID; COLON ADENOCARCINOMA; CONFERENCE PAPER; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; FIBROBLAST; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; NEUROENDOCRINE TUMOR; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; STOMACH ADENOCARCINOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELL COMMUNICATION; CHROMOGRANIN A; HUMANS; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE FRAGMENTS; TUMOR MICROENVIRONMENT;

ANIMALIA;

EID: 79151484434     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-010-9587-8     Document Type: Conference Paper

References (51)

1. D Aderka 1996 The potential biological and clinical significance of the soluble tumor necrosis factor receptors Cytokine Growth Factor Rev 7 231 240 1:CAS:528:DyaK2sXht1Sk 10.1016/S1359-6101(96)00026-3 8971478
2. GM Anderson MT Nakada M DeWitte 2004 Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer Curr Opin Pharmacol 4 314 320 1:CAS:528:DC%2BD2cXls1Wgurg%3D 10.1016/j.coph.2004.04.004 15251122
3. RH Angeletti S Aardal G Serck-Hanssen P Gee KB Helle 1994 Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A Acta Physiol Scand 152 11 19 1:CAS:528:DyaK2cXmvFaqtLs%3D 10.1111/j.1748-1716.1994. tb09780.x 7810329
4. D Belloni S Scabini C Foglieni L Veschini A Giazzon B Colombo A Fulgenzi KB Helle ME Ferrero A Corti E Ferrero 2007 The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration FASEB J 21 3052 3062 1:CAS:528:DC%2BD2sXhtFKntbvM 10.1096/fj.06- 6829com 17566084
5. A Blois H Holmsen G Martino A Corti MH Metz-Boutigue KB Helle 2006 Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine Regul Pept 134 30 37 1:CAS:528:DC%2BD28XhvVWiu7g%3D 10.1016/j.regpep.2005.11.003 16445995
6. A Blois B Srebro M Mandalà A Corti KB Helle G Serck-Hanssen 2006 The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells Regul Pept 135 78 84 1:CAS:528: DC%2BD28Xltl2iur4%3D 10.1016/j.regpep.2006.04.007 16725215
7. A Bretscher K Edwards RG Fehon 2002 ERM proteins and merlin: integrators at the cell cortex Nat Rev Mol Cell Biol 3 586 599 1:CAS:528: DC%2BD38XlslGrtbc%3D 10.1038/nrm882 12154370
8. C Ceconi R Ferrari T Bachetti C Opasich M Volterrani B Colombo G Parrinello A Corti 2002 Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality Eur Heart J 23 967 974 1:CAS:528: DC%2BD38XlvFWisbw%3D 10.1053/euhj.2001.2977 12069452
9. J Ciesielski-Treska G Ulrich L Taupenot S Chasserot-Golaz A Corti D Aunis MF Bader 1998 Chromogranin A induces a neurotoxic phenotype in brain microglial cells J Biol Chem 273 14339 14346 1:CAS:528:DyaK1cXjs1Oru74%3D 10.1074/jbc.273.23.14339 9603942
10. B Colombo F Curnis C Foglieni A Monno G Arrigoni A Corti 2002 Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models Cancer Res 62 941 946 1:CAS:528: DC%2BD38Xht1Kqs78%3D 11830555
11. B Colombo R Longhi C Marinzi F Magni A Cattaneo SH Yoo F Curnis A Corti 2002 Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion J Biol Chem 277 45911 45919 1:CAS:528:DC%2BD38XovFKisLk%3D 10.1074/jbc.M202637200 12297497
12. A Corti E Ferrero 2004 Chromogranin A: more than a marker for tumor diagnosis and prognosis Curr Med Chem-Immunol Endocr Metab Agents 4 161 167 1:CAS:528:DC%2BD2cXmsFCisr4%3D 10.2174/1568013043357626
13. A Corti A Gasparri FX Chen M Pelagi A Brandazza A Sidoli AG Siccardi 1996 Characterisation of circulating chromogranin A in human cancer patients Br J Cancer 73 924 932 1:CAS:528:DyaK28XjtFKhur8%3D 8611427
14. A Corti R Ferrari C Ceconi 2000 Chromogranin A and tumor necrosis factor alpha in heart failure Adv Exp Med Biol 482 351 359 1:CAS:528: DC%2BD3MXitFags7w%3D 10.1007/0-306-46837-9-28 11192595
15. LJ Deftos 1991 Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker Endocr Rev 12 181 187 1:CAS:528:DyaK3MXlslCksLw%3D 10.1210/edrv-12-2-181 2070778
16. G Di Comite CM Rossi A Marinosci K Lolmede E Baldissera P Aiello RB Mueller M Herrmann RE Voll P Rovere-Querini MG Sabbadini A Corti AA Manfredi 2009 Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation J Leukoc Biol 85 81 87 1:CAS:528:DC%2BD1MXjt12jtg%3D%3D 10.1189/jlb.0608358 18832606
17. E Dondossola A Gasparri A Bachi R Longhi MH Metz-Boutigue B Tota KB Helle F Curnis A Corti 2010 Role of vasostatin-1 C-terminal region in fibroblast cell adhesion Cell Mol Life Sci 12 2107 2118 10.1007/s00018-010-0319-5
18. E Ferrero S Scabini E Magni C Foglieni D Belloni B Colombo F Curnis A Villa ME Ferrero A Corti 2004 Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage FASEB J 20 20
19. Fiers W (1995) Biologic therapy with TNF: preclinical studies. In: De Vita V, Hellman S, Rosenberg S (eds) Biologic therapy of cancer: principles and practice. J.B. Lippincott Company, Philadelphia, pp 295-327
20. A Gasparri A Sidoli LP Sanchez R Longhi AG Siccardi PC Marchisio A Corti 1997 Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain J Biol Chem 272 20835 20843 1:CAS:528:DyaK2sXlsFKgtbw%3D 10.1074/jbc.272.33.20835 9252409
21. M Giusti M Sidoti C Augeri C Rabitti F Minuto 2004 Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man Eur J Endocrinol 150 299 303 1:CAS:528: DC%2BD2cXivFCktrg%3D 10.1530/eje.0.1500299 15012614
22. V Gregorc A Spreafico I Floriani B Colombo V Ludovini L Pistola G Bellezza MG Vigano E Villa A Corti 2007 Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer Cancer 110 845 853 1:CAS:528:DC%2BD2sXhtVajsrfI 10.1002/cncr.22856 17599769
23. AW Griffioen G Molema 2000 Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol Rev 52 237 268 1:CAS:528:DC%2BD3cXks1SksLw%3D 10835101
24. KB Helle A Corti MH Metz-Boutigue B Tota 2007 The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties Cell Mol Life Sci 64 2863 2886 1:CAS:528:DC%2BD2sXhsVals7jL 10.1007/s00018-007-7254-0 17717629
25. B Helpap J Kollermann 2001 Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch 438 86 91 1:CAS:528:DC%2BD3MXlt1Oitw%3D%3D 10.1007/s004280000337 11213840
26. A Iyoda K Hiroshima T Toyozaki Y Haga T Fujisawa H Ohwada 2001 Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology Cancer 91 1992 2000 1:STN:280:DC%2BD3MzhvFaqtw%3D%3D 10.1002/1097-0142(20010601)91:11<1992::AID- CNCR1224>3.0.CO;2-5 11391577
27. ET Janson L Holmberg M Stridsberg B Eriksson E Theodorsson E Wilander K Oberg 1997 Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center Ann Oncol 8 685 690 1:STN:280: DyaK2svkt1Sjtg%3D%3D 10.1023/A:1008215730767 9296223
28. N Kimura R Yoshida S Shiraishi M Pilichowska N Ohuchi 2002 Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma Endocr Pathol 13 117 122 1:CAS:528:DC%2BD38Xmsl2jurY%3D 10.1385/EP:13:2:117 12165659
29. MD Kramer J Reinartz G Brunner V Schirrmacher 1994 Plasmin in pericellular proteolysis and cellular invasion Invasion Metastasis 14 210 222 1:CAS:528:DyaK2MXovF2mtrY%3D 7657514
30. K Lugardon R Raffner Y Goumon A Corti A Delmas P Bulet D Aunis MH Metz-Boutigue 2000 Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A J Biol Chem 275 10745 10753 1:CAS:528:DC%2BD3cXislShsr0%3D 10.1074/jbc.275.15.10745 10753865
31. K Lugardon S Chasserot-Golaz AE Kieffer R Maget-Dana G Nullans B Kieffer D Aunis MH Metz-Boutigue 2001 Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide J Biol Chem 276 35875 35882 1:CAS:528:DC%2BD3MXntFaht7s%3D 10.1074/jbc.M104670200 11451958
32. SK Mahata M Mahata MM Fung DT O'Connor 2010 Catestatin: a multifunctional peptide from chromogranin A Regul Pept 162 33 43 1:CAS:528:DC%2BC3cXlvVGis74%3D 10.1016/j.regpep.2010.01.006 20116404
33. M Mandalà M Stridsberg KB Helle G Serck-Hanssen 2000 Endothelial handling of chromogranin A Adv Exp Med Biol 482 167 178 10.1007/0-306-46837-9-13 11192578
34. AI Minchinton IF Tannock 2006 Drug penetration in solid tumours Nat Rev Cancer 6 583 592 1:CAS:528:DC%2BD28XntFGlu7w%3D 10.1038/nrc1893 16862189
35. DT O'Connor LJ Deftos 1986 Secretion of chromogranin A by peptide-producing endocrine neoplasms New Engl J Med 314 1145 1151 10.1056/NEJM198605013141803 3007986
36. M Pieroni A Corti B Tota F Curnis T Angelone B Colombo MC Cerra F Bellocci F Crea A Maseri 2007 Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function Eur Heart J 28 1117 1127 1:CAS:528:DC%2BD2sXnsFGqsLw%3D 10.1093/eurheartj/ehm022 17389654
37. Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M (2010) Granins and granin-related peptides in neuroendocrine tumours. Regul Pept (in press)
38. S Ratti F Curnis R Longhi B Colombo A Gasparri F Magni E Manera MH Metz-Boutigue A Corti 2000 Structure-activity relationships of chromogranin A in cell adhesion. Identification and characterization of an adhesion site for fibroblasts and smooth muscle cells J Biol Chem 275 29257 29263 1:CAS:528:DC%2BD3cXmvFGqu7w%3D 10.1074/jbc.M003796200 10875933
39. J Russell P Gee SM Liu RH Angeletti 1994 Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides Endocrinology 135 337 342 1:CAS:528:DyaK2cXkslCjurk%3D 10.1210/en.135.1.337 8013369
40. JP Simon D Aunis 1989 Biochemistry of the chromogranin A protein family Biochem J 262 1 13 1:CAS:528:DyaL1MXls12nsbw%3D 2684154
41. M Stridsberg RH Angeletti KB Helle 2000 Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods J Endocrinol 165 703 714 1:CAS:528:DC%2BD3cXktl2qt78%3D 10.1677/joe.0.1650703 10828855
42. PW Szlosarek FR Balkwill 2003 Tumour necrosis factor alpha: a potential target for the therapy of solid tumours Lancet Oncol 4 565 573 1:CAS:528:DC%2BD3sXntVGhsrs%3D 10.1016/S1470-2045(03)01196-3 12965278
43. L Taupenot KL Harper DT O'Connor 2003 The chromogranin-secretogranin family New Engl J Med 348 1134 1149 1:CAS:528:DC%2BD3sXit1Smur4%3D 10.1056/NEJMra021405 12646671
44. B Tota T Angelone R Mazza MC Cerra 2008 The chromogranin A-derived vasostatins: new players in the endocrine heart Curr Med Chem 15 1444 1451 1:CAS:528:DC%2BD1cXnsVyhs7k%3D 10.2174/092986708784567662 18537621
45. O Tredan CM Galmarini K Patel IF Tannock 2007 Drug resistance and the solid tumor microenvironment J Natl Cancer Inst 99 1441 1454 1:CAS:528:DC%2BD2sXht1yltbrO 10.1093/jnci/djm135 17895480
46. V Turquier H Vaudry S Jegou Y Anouar 1999 Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A gene expression in the pars intermedia of the pituitary during background color adaptation Endocrinology 140 4104 4112 1:CAS:528:DyaK1MXlslSrt7s%3D 10.1210/en.140.9.4104 10465282
47. J Waltenberger L Claesson-Welsh A Siegbahn M Shibuya CH Heldin 1994 Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J Biol Chem 269 26988 26995 1:CAS:528:DyaK2cXmt1artb4%3D 7929439
48. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL (2000) Carcinoma of the prostate gland (excluding unusual variants and secondary carcinomas). In: Rosai J, Sobin LH (eds) Atlas of tumor pathology, vol 28. Armed Forces Institute of Pathology, Washington, DC, pp 111-216
49. K Zhang F Rao G Wen RM Salem S Vaingankar M Mahata NR Mahapatra EO Lillie PE Cadman RS Friese BA Hamilton VY Hook SK Mahata L Taupenot DT O'Connor 2006 Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin Diabetes Obes Metab 8 621 633 1:CAS:528:DC%2BD28XhtlSks7nE 10.1111/j.1463-1326.2006.00575.x 17026486
50. D Zhang P Shooshtarizadeh BJ Laventie DA Colin JF Chich J Vidic J de Barry S Chasserot-Golaz F Delalande A Van Dorsselaer F Schneider K Helle D Aunis G Prevost MH Metz-Boutigue 2009 Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2 PLoS One 4 e4501 10.1371/journal.pone.0004501 19225567
51. MG Ziegler B Kennedy E Morrissey DT O'Connor 1990 Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure Kidney Int 37 1357 1362 1:STN:280:DyaK3c3msFSiuw%3D%3D 10.1038/ki.1990.122 2345431